Holen Sie sich die Stockscreener-App
63.39
0.62%
0.39
Handel nachbörslich:
63.48
0.09
+0.14%
Schlusskurs vom Vortag:
$63.00
Offen:
$62.29
24-Stunden-Volumen:
1.54M
Relative Volume:
0.91
Marktkapitalisierung:
$7.69B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
25.98
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
-2.30%
1M Leistung:
-8.14%
6M Leistung:
-3.38%
1J Leistung:
-10.73%
1-Tages-Spanne:
$62.21
$63.81
1-Wochen-Bereich:
$62.21
$65.15
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
63.39 | 7.64B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
781.90 | 95.71B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
317.93 | 61.46B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
154.19 | 36.66B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
AHG
Akso Health Group Adr
|
1.66 | 939.13M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Building trade automation scripts for Henry Schein Inc.2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Leerink Partners Adjusts Price Target on Henry Schein to $71 From $72, Maintains Market Perform Rating - MarketScreener
Can Henry Schein Inc. stock hit analyst price targetsPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Will Henry Schein Inc. bounce back from current supportMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Is Henry Schein Inc. stock dividend yield sustainablePortfolio Value Summary & Weekly Momentum Stock Picks - newser.com
Analyzing drawdowns of Henry Schein Inc. with statistical toolsSwing Trade & Reliable Volume Spike Alerts - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 15.93% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats - MSN
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC) - The Globe and Mail
Henry Schein Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Is Henry Schein Inc. stock ready for a breakout2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
What institutional flow reveals about Henry Schein Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
How sentiment analysis helps forecast Henry Schein Inc.Quarterly Profit Summary & Smart Money Movement Alerts - newser.com
Weiss Ratings Reaffirms Hold (C) Rating for Henry Schein (NASDAQ:HSIC) - MarketBeat
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead - The Globe and Mail
Peering Into Henry Schein Inc's Recent Short Interest - Sahm
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein subsidiary allegedly compromised by Lynx ransomware - scworld.com
July 2026 Options Now Available For Henry Schein (HSIC) - Nasdaq
Understanding Henry Schein Inc.’s price movement2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Tick level data insight on Henry Schein Inc. volatilityWeekly Profit Recap & Real-Time Stock Price Movement Reports - newser.com
Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET - ADVFN
How to forecast Henry Schein Inc. trends using time seriesMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of Henry Schein Inc. stock performanceJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Henry Schein Announces $400 Million Share Repurchase Plan - ADVFN
What Fibonacci levels say about Henry Schein Inc. rebound2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com
Henry Schein Reports Record Second-Quarter 2021 Financial Results From Continuing Operations - ADVFN
Henry Schein (NASDAQ:HSIC) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Henry Schein subsidiary confirms ransomware attack - Cybernews
Is Henry Schein Inc. stock bottoming outTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Using Ichimoku Cloud for Henry Schein Inc. technicalsMarket Risk Analysis & Consistent Profit Trading Strategies - newser.com
How to manage a losing position in Henry Schein Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Is now a turning point for Henry Schein Inc.July 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
Applications Open for 2025 Henry Schein Student Outreach Grants - Orthodontic Products
Barrington Research Maintains Price Target on Henry Schein at $78, Rating is Outperform - MarketScreener
Barrington Research Adjusts PT on Henry Schein to $56 From $78, Maintains Outperform Rating - MarketScreener
Henry Schein Cares Opens Applications for its Global Student Outreach Program - Dentistry Today
Subscribili Joins Henry Schein One API Exchange as an Authorized Integration Vendor - PRWeb
What Does Henry Schein, Inc.'s (NASDAQ:HSIC) Share Price Indicate? - 富途牛牛
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.92%
3.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):